Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas. [electronic resource]
Producer: 20170425Description: 1377-1382 p. digitalISSN:- 1720-8386
- Adult
- Aged
- Biomarkers -- blood
- Cabergoline
- Dopamine Agonists -- therapeutic use
- Ergolines -- therapeutic use
- Female
- Humans
- Hyperprolactinemia -- diagnosis
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- diagnosis
- Pituitary Neoplasms -- complications
- Prognosis
- Prolactinoma -- complications
- Tomography, X-Ray Computed -- methods
- Withholding Treatment
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.